An interview with Veranova’s CCO, Cécile Maupas and CTO, Rohtash Kumar

The Veranova commercial and technical teams had a great time at CPHI Milan 2024 last month. They enjoyed connecting with customers and learning about the latest developments in the pharmaceutical industry.

At the event, our SVP, Chief Commercal Officer, Cécile Maupas and SVP, Chief Technology Officer, Rohtash Kumar were interviewed by 24/7 Biopharma.

“At Veranova, our core values of people, patients, and innovation will remain at the heart of everything we do. We are committed to developing top talent and investing in cutting-edge capabilities to serve the needs of the evolving pharmaceutical landscape.

“Together with our partners, we will continue shaping the future of the pharmaceutical industry, and ultimately delivering life-changing medications to patients across the world.”

Watch the video below to learn more about Cécile and Rohtash’s thoughts on the trends in the industry and the role of CDMOs like Veranova.